Myf-5 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
TGF-β receptor inhibitor. By blocking TGF-β signaling, it indirectly affects Myf-5 expression. TGF-β is known to regulate myogenic differentiation, and inhibiting its receptor can modulate the cellular environment, influencing Myf-5 levels and myogenesis. | ||||||
LY 364947 | 396129-53-6 | sc-203122 sc-203122A | 5 mg 10 mg | $105.00 $153.00 | 4 | |
Another TGF-β receptor inhibitor, disrupting the TGF-β pathway. This influences myogenic differentiation and indirectly inhibits Myf-5 expression. By impeding TGF-β signaling, LY364947 alters the cellular milieu, impacting the regulatory network that governs Myf-5 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. While not directly targeting Myf-5, SP600125 disrupts the JNK pathway. Myf-5 expression is influenced by JNK signaling, so inhibiting this pathway with SP600125 can indirectly modulate Myf-5 levels and alter the cellular context relevant to myogenesis. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor. Acting on the MAPK pathway, PD98059 indirectly impacts Myf-5. This compound hinders the activation of MEK, an upstream regulator of MAPK. As Myf-5 is influenced by the MAPK pathway, inhibiting MEK alters the signaling cascade, potentially downregulating Myf-5 expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor. By targeting the PI3K/Akt pathway, Wortmannin indirectly modulates Myf-5. This compound impedes PI3K activity, influencing downstream signaling cascades that regulate Myf-5 expression. The inhibition of PI3K alters the cellular environment, impacting myogenic processes and Myf-5 levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor. Indirectly affecting Myf-5, Rapamycin disrupts the mTOR pathway. As mTOR is involved in myogenic differentiation, inhibiting it alters the cellular context, influencing Myf-5 expression. Rapamycin can modulate the regulatory network governing myogenesis and Myf-5 activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitor. While not directly acting on Myf-5, Trichostatin A impacts the epigenetic regulation of genes, including those involved in myogenesis. By inhibiting HDAC, it alters chromatin accessibility, potentially affecting Myf-5 expression indirectly through epigenetic modifications. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
DNA-damaging agent. Indirectly influencing Myf-5 by disrupting DNA integrity. Cisplatin induces DNA damage, activating cellular responses that may impact Myf-5 expression. The altered genomic landscape due to DNA damage can modulate the regulatory network governing Myf-5 and myogenic processes. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Antimetabolite affecting nucleotide synthesis. While not directly targeting Myf-5, 5-Fluorouracil disrupts nucleotide metabolism, potentially impacting cellular processes related to Myf-5 expression. The altered nucleotide pool can indirectly influence the regulatory network governing Myf-5 and myogenesis. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Broad-spectrum kinase inhibitor. Indirectly influencing Myf-5 by targeting multiple signaling pathways. Staurosporine's broad kinase inhibition alters the cellular signaling milieu, potentially affecting Myf-5 expression indirectly. It modulates various pathways contributing to the regulatory network governing Myf-5. | ||||||